Whereas CD8+ T cells and IFNγ-producing Thelper (Th) 1 cells exhibit potent anti-tumor functions and are generally of good prognosis in solid tumors [126,127], their Foxp3+ regulatory T cell (Treg cells) counterparts are master inhibitors of cancer immunity (reviewed in [128]). The gene discussed is CD8A; the disease is neoplasm.